Evaluation of ongoing mepolizumab treatment in chronic rhinosinusitis with nasal polyps

Chronic rhinosinusitis with nasal polyps (CRSwNP) is a multifactorial inflammatory disease of the mucous membranes of the nose and paranasal sinuses. Eosinophilic inflammation is described as a common endotype. The anti-interleukin-5 (IL-5) antibody mepolizumab was approved in November 2021 as an ad...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Ludger Klimek, Ulrike Förster-Ruhrmann, Heidi Olze, Achim G. Beule, Adam M. Chaker, Jan Hagemann, Tilmann Huppertz, Thomas K. Hoffmann, Stefan Dazert, Thomas Deitmer, Sebastian Strieth, Holger Wrede, Wolfgang Schlenter, Hans-Jürgen Welkoborsky, Barbara Wollenberg, Sven Becker, Frederike Bärhold, Felix Klimek, Ingrid Casper, Jaron Zuberbier, Claudia Rudack, Mandy Cuevas, Constantin A. Hintschich, Orlando Guntinas-Lichius, Timo Stöver, Christoph Bergmann, Pascal Werminghaus, Oliver Pfaar, Jan Gosepath, Moritz Gröger, Caroline Beutner, Martin Laudien, Rainer K. Weber, Tanja Hildenbrand, Anna-Sophie Hoffmann, Claus Bachert
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	Open Exploration Publishing Inc. 2024-02-01
Cyfres:	Exploration of Asthma & Allergy
Pynciau:	chronic rhinosinusitis chronic rhinosinusitis with nasal polyps biologics eosinophilic inflammation mepolizumab
Mynediad Ar-lein:	https://www.explorationpub.com/uploads/Article/A100927/100927.pdf
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!